We are live on ! Find out more
NRC icon

NRC Health Common Stock

123 hedge funds and large institutions have $147M invested in NRC Health Common Stock in 2025 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 52 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.47% less ownership

Funds ownership: 50.59%50.12% (-0.47%)

8% less funds holding

Funds holding: 133123 (-10)

30% less capital invested

Capital invested by funds: $210M → $147M (-$62.3M)

33% less repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 52

39% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 23

Holders
123
Holders Change
-10
Holders Change %
-7.52%
% of All Funds
1.65%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
14
Increased
35
Reduced
52
Closed
23
Calls
$9K
Puts
Net Calls
+$9K
Net Calls Change

NRC Hedge Fund Activity: Q1 2025 in Review

123 of the 7,472 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q1 2025, worth a combined $147M — down 30% from $210M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of NRC and 14 opened new positions — a net loss of 9 holders — while 52 trimmed existing stakes and 35 added.

The largest buyer was Citadel Advisors, adding an estimated $1.31M. The largest seller was Algert Global, exiting entirely with an estimated $1.4M sold.

  • 123 institutional investors held NRC Health Common Stock (NRC) as of Q1 2025, down from 133 in Q4 2024.
  • Funds reported $147M of NRC Health Common Stock stock for Q1 2025, down 30% quarter-over-quarter.
  • 14 funds opened new NRC Health Common Stock positions in Q1 2025 and 23 closed out, a net change of -9 holders.
  • The largest NRC Health Common Stock buyer in Q1 2025 was Citadel Advisors, an estimated $1.31M added.
  • The largest NRC Health Common Stock seller in Q1 2025 was Algert Global, an estimated $1.4M sold.

Based on aggregated 13F filings for Q1 2025.